237 related articles for article (PubMed ID: 17483297)
1. Noncanonical NF-kappaB signaling in dendritic cells is required for indoleamine 2,3-dioxygenase (IDO) induction and immune regulation.
Tas SW; Vervoordeldonk MJ; Hajji N; Schuitemaker JH; van der Sluijs KF; May MJ; Ghosh S; Kapsenberg ML; Tak PP; de Jong EC
Blood; 2007 Sep; 110(5):1540-9. PubMed ID: 17483297
[TBL] [Abstract][Full Text] [Related]
2. Chimeric Vaccine Stimulation of Human Dendritic Cell Indoleamine 2, 3-Dioxygenase Occurs via the Non-Canonical NF-κB Pathway.
Kim NS; Mbongue JC; Nicholas DA; Esebanmen GE; Unternaehrer JJ; Firek AF; Langridge WH
PLoS One; 2016; 11(2):e0147509. PubMed ID: 26881431
[TBL] [Abstract][Full Text] [Related]
3. Indoleamine 2,3-Dioxygenase Activation by Interferon Gamma in Vascular Endothelial Rat Cells Requires Noncanonical NF-κB Signaling.
Liang Y; Yu Z; Song Y; Wang T; Xiao B
Transplant Proc; 2019; 51(6):2141-2145. PubMed ID: 31307771
[TBL] [Abstract][Full Text] [Related]
4. Activation of the noncanonical NF-κB pathway by HIV controls a dendritic cell immunoregulatory phenotype.
Manches O; Fernandez MV; Plumas J; Chaperot L; Bhardwaj N
Proc Natl Acad Sci U S A; 2012 Aug; 109(35):14122-7. PubMed ID: 22879398
[TBL] [Abstract][Full Text] [Related]
5. Regulation of human auto- and alloreactive T cells by indoleamine 2,3-dioxygenase (IDO)-producing dendritic cells: too much ado about IDO?
Terness P; Chuang JJ; Bauer T; Jiga L; Opelz G
Blood; 2005 Mar; 105(6):2480-6. PubMed ID: 15572592
[TBL] [Abstract][Full Text] [Related]
6. Curcumin suppresses the induction of indoleamine 2,3-dioxygenase by blocking the Janus-activated kinase-protein kinase Cdelta-STAT1 signaling pathway in interferon-gamma-stimulated murine dendritic cells.
Jeong YI; Kim SW; Jung ID; Lee JS; Chang JH; Lee CM; Chun SH; Yoon MS; Kim GT; Ryu SW; Kim JS; Shin YK; Lee WS; Shin HK; Lee JD; Park YM
J Biol Chem; 2009 Feb; 284(6):3700-8. PubMed ID: 19075017
[TBL] [Abstract][Full Text] [Related]
7. Novel regulation of CD80/CD86-induced phosphatidylinositol 3-kinase signaling by NOTCH1 protein in interleukin-6 and indoleamine 2,3-dioxygenase production by dendritic cells.
Koorella C; Nair JR; Murray ME; Carlson LM; Watkins SK; Lee KP
J Biol Chem; 2014 Mar; 289(11):7747-62. PubMed ID: 24415757
[TBL] [Abstract][Full Text] [Related]
8. IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-kappaB activation.
Puccetti P; Grohmann U
Nat Rev Immunol; 2007 Oct; 7(10):817-23. PubMed ID: 17767193
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cells have the option to express IDO-mediated suppression or not.
Munn DH; Mellor AL; Rossi M; Young JW
Blood; 2005 Mar; 105(6):2618. PubMed ID: 15746089
[No Abstract] [Full Text] [Related]
10. Der p 1 suppresses indoleamine 2, 3-dioxygenase in dendritic cells from house dust mite-sensitive patients with asthma.
Maneechotesuwan K; Wamanuttajinda V; Kasetsinsombat K; Huabprasert S; Yaikwawong M; Barnes PJ; Wongkajornsilp A
J Allergy Clin Immunol; 2009 Jan; 123(1):239-48. PubMed ID: 19058839
[TBL] [Abstract][Full Text] [Related]
11. Hemoglobin induces the expression of indoleamine 2,3-dioxygenase in dendritic cells through the activation of PI3K, PKC, and NF-kappaB and the generation of reactive oxygen species.
Ogasawara N; Oguro T; Sakabe T; Matsushima M; Takikawa O; Isobe K; Nagase F
J Cell Biochem; 2009 Oct; 108(3):716-25. PubMed ID: 19693771
[TBL] [Abstract][Full Text] [Related]
12. Decreased indoleamine 2,3-dioxygenase expression in dendritic cells and role of indoleamine 2,3-dioxygenase-expressing dendritic cells in immune thrombocytopenia.
Xu SQ; Wang CY; Zhu XJ; Dong XY; Shi Y; Peng J; Qin P; Sun JZ; Guo C; Ni H; Hou M
Ann Hematol; 2012 Oct; 91(10):1623-31. PubMed ID: 22526360
[TBL] [Abstract][Full Text] [Related]
13. Astrocyte indoleamine 2,3-dioxygenase is induced by the TLR3 ligand poly(I:C): mechanism of induction and role in antiviral response.
Suh HS; Zhao ML; Rivieccio M; Choi S; Connolly E; Zhao Y; Takikawa O; Brosnan CF; Lee SC
J Virol; 2007 Sep; 81(18):9838-50. PubMed ID: 17626075
[TBL] [Abstract][Full Text] [Related]
14. The role of indoleamine 2,3-dioxygenase-aryl hydrocarbon receptor pathway in the TLR4-induced tolerogenic phenotype in human DCs.
Salazar F; Awuah D; Negm OH; Shakib F; Ghaemmaghami AM
Sci Rep; 2017 Mar; 7():43337. PubMed ID: 28256612
[TBL] [Abstract][Full Text] [Related]
15. Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase.
Mellor AL; Chandler P; Baban B; Hansen AM; Marshall B; Pihkala J; Waldmann H; Cobbold S; Adams E; Munn DH
Int Immunol; 2004 Oct; 16(10):1391-401. PubMed ID: 15351783
[TBL] [Abstract][Full Text] [Related]
16. Sodium butyrate inhibits interferon-gamma induced indoleamine 2,3-dioxygenase expression via STAT1 in nasopharyngeal carcinoma cells.
He YW; Wang HS; Zeng J; Fang X; Chen HY; Du J; Yang XY
Life Sci; 2013 Oct; 93(15):509-15. PubMed ID: 23942267
[TBL] [Abstract][Full Text] [Related]
17. Cutting edge: Autocrine TGF-beta sustains default tolerogenesis by IDO-competent dendritic cells.
Belladonna ML; Volpi C; Bianchi R; Vacca C; Orabona C; Pallotta MT; Boon L; Gizzi S; Fioretti MC; Grohmann U; Puccetti P
J Immunol; 2008 Oct; 181(8):5194-8. PubMed ID: 18832670
[TBL] [Abstract][Full Text] [Related]
18. Are indoleamine-2,3-dioxygenase producing human dendritic cells a tool for suppression of allogeneic T-cell responses?
Löb S; Ebner S; Wagner S; Weinreich J; Schäfer R; Königsrainer A
Transplantation; 2007 Feb; 83(4):468-73. PubMed ID: 17318080
[TBL] [Abstract][Full Text] [Related]
19. Flavivirus infection induces indoleamine 2,3-dioxygenase in human monocyte-derived macrophages via tumor necrosis factor and NF-κB.
Yeung AW; Wu W; Freewan M; Stocker R; King NJ; Thomas SR
J Leukoc Biol; 2012 Apr; 91(4):657-66. PubMed ID: 22301793
[TBL] [Abstract][Full Text] [Related]
20. A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type I IFN signaling following B7 ligation.
Baban B; Hansen AM; Chandler PR; Manlapat A; Bingaman A; Kahler DJ; Munn DH; Mellor AL
Int Immunol; 2005 Jul; 17(7):909-19. PubMed ID: 15967784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
